Proteolix : a "me-too" success / Larry Lasky.

Format:

Book

Author/Creator:

Lasky, Larry, author.

Series:

SAGE Knowledge. Cases.

SAGE Knowledge. Cases

Language:

English

Subjects (All):

Proteolix.

Business planning.

Biotechnology industries.

Physical Description:

1 online resource.

Place of Publication:

London : SAGE Publications Ltd, 2017.

System Details:

text file

Summary:

In an industry rife with failures, Proteolix, a biotechnology company, was a rare success. The Proteolix case provides a compelling example of a biotech company that has chosen a "me-too" strategy, a less risky strategy than the strategy of discovering a drug for a novel target. However, even me-too drug strategies in the biotech industry face an uphill battle. The protagonist, Susan Molineaux, along with her team, faced many challenges along the way and the case study provides students with a map of some of her key decisions at important points in the company's history. The case study asks students to evaluate Molineaux's and her teams decisions and to identify the company's drivers of success. The Proteolix case also allows students to understand the biotechnology industry, its unique challenges, and the particular challenges facing a me-too drug company that is attempting to dislodge a drug to treat life-threatening indications.

Notes:

Originally published: Lasky, L. (2012). Proteolix: A "me-too" success. The Berkeley-Haas Case Series. University of California, Berkeley. Haas School of Business.

No ILL or scholarly sharing allowed.

Description based on XML content.

ISBN:

9781526409614

OCLC:

1017720744

Access Restriction:

Restricted for use by site license.